Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.
The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently in a phase I trial to treat ovarian cancer. This is the world's first IgE therapeutic to enter the clinic.
Company Details
- Employees
- 30
- Founded
- -
- Address
- Waterfront, Arc West London,manbre Road,united Kingdom
- Phone
- +44 (0) 203 657 7612
- in****@****ics.com
- Industry
- Biotechnology
- Website
- epsilogen.com
- HQ
- Hammersmith
Epsilogen Ltd Questions
Epsilogen Ltd's helpline number is +44 (0) 203 657 7612
Epsilogen Ltd's website is epsilogen.com
Epsilogen Ltd's LinkedIn profile is https://uk.linkedin.com/company/epsilogen-ltd
Epsilogen Ltd has
30 employees.
View email and phone details for 30
employees at Epsilogen Ltd.
Epsilogen Ltd's industry is
Biotechnology
Epsilogen Ltd's top competitors are
Safi Biotherapeutics Inc,
Pantera,
Phoremost Ltd,
Nanosyrinx,
Onl Therapeutics,
F2g,
Vironexis Biotherapeutics,
Radiant Biotherapeutics,
Inflammatix, Inc.,
Cardiatec Bio.
Epsilogen Ltd's support email address is info@igemtherapeutics.com
Epsilogen Ltd's categories are Biotechnology
Epsilogen Ltd's founding year is 2016
